Quest Diagnostics Inc logo

DGX - Quest Diagnostics Inc News Story

$111.32 -3.9  -3.4%

Last Trade - 23/09/20

Sector
Healthcare
Size
Large Cap
Market Cap £12.16bn
Enterprise Value £15.07bn
Revenue £5.92bn
Position in Universe 549th / 6389

BRIEF-Quest Diagnostics Surpasses 10 mln COVID-19 Molecular Diagnostic Test Results Delivered To Date

Mon 3rd August, 2020 11:18pm
Aug 3 (Reuters) - Quest Diagnostics Inc  DGX.N :
    * QUEST DIAGNOSTICS INC - DURING PAST WEEK, QUEST SURPASSED
10
MILLION COVID-19 MOLECULAR DIAGNOSTIC TEST RESULTS DELIVERED TO
DATE
    * QUEST DIAGNOSTICS INC - IN RECENT DAYS, DEMAND FOR CO'S
COVID-19
MOLECULAR DIAGNOSTIC TESTING HAS PLATEAUED, ALBEIT AT HIGH LEVEL
    * QUEST DIAGNOSTICS - NOW HAVE CAPACITY TO PERFORM 150,000
COVID-19 MOLECULAR DIAGNOSTIC TESTS A DAY
    * QUEST DIAGNOSTICS INC -  EXPECT THIS WEEK TO BE THE THIRD
CONSECUTIVE WEEK IN WHICH CO'S CAPACITY WILL EXCEED TEST ORDERS
    * QUEST DIAGNOSTICS - HAVE REPORTED 3.0 MILLION COVID-19
ANTIBODY
TESTS TO DATE, WITH AVERAGE TURNAROUND TIME OF 1-2 DAYS
    * QUEST DIAGNOSTICS INC - AVERAGE TURNAROUND TIME FOR
MOLECULAR
DIAGNOSTIC AND ANTIBODY TESTING IS 5 DAYS & IS EXPECTED TO BE 3
DAYS BY NEXT WEEK

Source text: https://bit.ly/3goV0kE
Further company coverage:  DGX.N 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.